Author

Christian Auclair

AB Science (France)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Abdellah Benjahad· 1 shared Alain Moussy· 1 shared Anaïs OudiniD· 1 shared Annette IvesiD· 1 shared Armelle GoubardiD· 1 shared Bassam JanjiiD· 1 shared Benoı̂t GigantiD· 1 shared Bérengère Hajem· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Abdellah Benjahad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ACB1801 enhances tumor immunogenicity by targeting glycolysis/ferroptosis vulnerability and activating STAT1-signaling to overcome anti-PD-1 resistance in MSS colorectal cancer

Ruize Gao, Kris Van Moer, Coralie Pulido, Anaïs Oudin, Chenxi Li, Margaux Poussard, teresa L Ramos, Diane Murera, Elisabetta Bartolini, Annette Ives, Marine Gerbé de Thoré, Michele Mondini, Éric Deutsch, Guy Berchem, Christian Auclair, Bassam Janji

ACB1801 enhances anti-PD-1 therapy efficacy in MSS CRC by reprogramming the TME through metabolic reprogramming and STAT1 signaling activation.

bioRxiv · Feb 25, 2026 · PreprintCancer Biology

Identification of AB8939, a novel synthetic microtubule destabilizer and ALDH inhibitor that overcomes multidrug resistance in tumor cells as a drug candidate for the treatment of refractory acute myeloid leukemia

Martine Humbert, Sébastien Letard, Armelle Goubard, Camille Montersino, Stéphane Audebert, Émilie Baudelet, Bérengère Hajem, Manuel L Neves, Samila Siavioshian, Paloma F. Varela, Benoı̂t Gigant, E. Rebuffet, Pascal Verdier‐Pinard, Rémy Castellano, Yves Collette, , Patrice C. Dubreuil

This paper identifies AB8939, a novel drug that targets microtubules and ALDH enzymes, showing efficacy against drug-resistant AML cells and models.

bioRxiv · Dec 12, 2025 · PreprintCell Biology